Gene · 8554
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDX5 and DDX17-multifaceted proteins in the regulation of tumorigenesis and tumor progression. | Front Oncol | 2022 | 35992805 | PubTator, text mining | PubMed |
| Low Frequency of p.S510G in PIAS1 Challenges its Relevance for Modifying Repeat Expansion Disorders. | Mov Disord | 2022 | 35984100 | PubTator, text mining | PubMed |
| Murine precursors to type 1 conventional dendritic cells induce tumor cytotoxicity and exhibit activated PD-1/PD-L1 pathway. | PLoS One | 2022 | 35980974 | PubTator, text mining | PubMed |
| Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. | Int J Mol Sci | 2022 | 35955729 | PubTator, text mining | PubMed |
| Evaluation of the role of KPNA2 mutations in breast cancer prognosis using bioinformatics datasets. | BMC Cancer | 2022 | 35948941 | PubTator, text mining | PubMed |
| MetastaSite: Predicting metastasis to different sites using deep learning with gene expression data. | Front Mol Biosci | 2022 | 35936793 | PubTator, text mining | PubMed |
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. | Cancers (Basel) | 2022 | 35892888 | PubTator, text mining | PubMed |
| SUMOylation and Major Depressive Disorder. | Int J Mol Sci | 2022 | 35887370 | PubTator, text mining | PubMed |
| Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases. | Int J Mol Sci | 2022 | 35887358 | PubTator, text mining | PubMed |
| Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers. | Int J Mol Sci | 2022 | 35886904 | PubTator, text mining | PubMed |
| Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease. | Biomolecules | 2022 | 35883466 | PubTator, text mining | PubMed |
| Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance. | Front Cell Dev Biol | 2022 | 35874824 | PubTator, text mining | PubMed |
| Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair. | Front Cell Dev Biol | 2022 | 35865631 | PubTator, text mining | PubMed |
| Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats. | Fac Rev | 2022 | 35865413 | PubTator, text mining | PubMed |
| Apoptotic caspases suppress an MDA5-driven IFN response during productive replication of human papillomavirus type 31. | Proc Natl Acad Sci U S A | 2022 | 35858339 | PubTator, text mining | PubMed |
| Role of Posttranslational Modifications of Proteins in Cardiovascular Disease. | Oxid Med Cell Longev | 2022 | 35855865 | PubTator, text mining | PubMed |
| Extended DNA-binding interfaces beyond the canonical SAP domain contribute to the function of replication stress regulator SDE2 at DNA replication forks. | J Biol Chem | 2022 | 35850305 | PubTator, text mining | PubMed |
| LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. | Nucleic Acids Res | 2022 | 35849344 | PubTator, text mining | PubMed |
| Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway. | Front Oncol | 2022 | 35847921 | PubTator, text mining | PubMed |
| A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells. | Exp Hematol Oncol | 2022 | 35831896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/papers?page=13